03 March 2022
MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, announces that Gareth Davies, Chief Financial and Operations Officer, will stand down and leave the Company on 7 April 2022 to pursue other opportunities.
Gareth joined MyHealthChecked in June 2021 and has supported the Company through a transitionary period, establishing robust financial processing and reporting systems as well as an efficient operations system. During this time, the Company has seen strong delivery through a dynamic growth phase and, with the infrastructure and new systems in place, is well placed to continue this growth through the launch of the Company's new at-home wellness tests in H1 2022.
The Company has initiated a search for a replacement Finance Director and a further announcement will be made in due course.
Penny McCormick, Chief Executive Officer of MyHealthChecked Plc, said: "I would like to thank Gareth for the critical role he has played in the past nine months at MyHealthChecked. During this time, we have achieved rapid growth and scale up, and Gareth leaves the infrastructure of MyHealthChecked in a position fitting for a public company entering a new phase of the business with COVID as a secondary business stream.
"Gareth has been a well-received member of the MyHealthChecked leadership team, and I wish him well in his future endeavours."
For further information contact:
Penny McCormick, Chief Executive Officer
via Walbrook PR
SPARK Advisory Partners Limited (NOMAD)
Tel: +44 (0)20 3368 3550
Oberon Capital Ltd (Broker)
Tel: +44 (0)203 179 5344
Walbrook PR Ltd (Media & IR)
Tel: +44 (0)20 7933 8780 or [email protected]
Paul McManus / Alice Woodings
Mob: +44(0)7980 541 893 / +44 (0)7407 804 654
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the acquisition of The Genome Store in November 2020. The tests will be made available online, and would be viable for over the counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.